Clinical Trial Update: Pipamperone/Citalopram (PipCit)Versus Citalopram in the Treatment of Major Depressive Disorder(MDD) [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing the combination Pipamperone/Citalopram (PipCit) to Citalopram in major depressive disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Citalopram (Citalopram hydrobromide)
• Pipamperone (pipamperone)

Snippet

Sponsor: PharmaNeuroBoost N.V. | Conditions: Depression | Phase 2 | Status: COMPLETED